MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals reply to clarification sought by the exchange

09 Jun 2015 Evaluate

The Exchange had sought clarification from GlaxoSmithKline Pharmaceuticals with respect to news appearing in Business Standard dated June 06, 2015 titled ‘CCI slaps Rs 64 cr fine on GlaxoSmithKline, Sanofi.’ GlaxoSmithKline Pharmaceuticals response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..